Profiling Response to Tumor Necrosis Factor Inhibitor Treatment in Axial Spondyloarthritis

Alazmi M., SARI İ., Krishnan B., Inman R. D., Haroon N.

ARTHRITIS CARE & RESEARCH, vol.70, no.9, pp.1393-1399, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 70 Issue: 9
  • Publication Date: 2018
  • Doi Number: 10.1002/acr.23465
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1393-1399
  • Dokuz Eylül University Affiliated: Yes


Objective. Lack of response to tumor necrosis factor inhibitor (TNFi) agents is not uncommon, encountered during the treatment of axial spondyloarthritis (SpA) patients, and it can be classified as primary lack of response (PLR) or secondary lack of response (SLR). The primary aim of this study was to evaluate factors associated with TNFi failure types and their characteristics in axial SpA.